Overview Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia Status: Completed Trial end date: 2008-08-01 Target enrollment: Participant gender: Summary The study is designed to assess the efficacy and safety of multiple infusions of conivaptan in subjects with euvolemic or hypervolemic hyponatremia Phase: Phase 3 Details Lead Sponsor: Cumberland PharmaceuticalsTreatments: Conivaptan